With over 30% of eating disorder patients utilizing GLP-1 medications, experts urge primary care clinicians to screen for ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic or Wegovy, have revolutionized type 2 diabetes and ...

Add Yahoo as a preferred source to see more of our stories on Google. In 2013, when Kate Regan was a senior in high school, she became fixated on health and nutrition. She found content from online ...

According to the study, the prevalence of GLP-1 use is higher among people with eating disorders than the general population.

Researchers at the Icahn School of Medicine at Mount Sinai and the Lieber Institute for Brain Development have identified ...

A new study is raising concerns about GLP-1 weight loss drugs and eating disorders. Researchers found that 32% of patients ...

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred Food always powered Anahi Araiza through study ...

This group may be taking the weight-loss drugs in contraindicated ways, researchers sugges ...

Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, ...

Bulimia nervosa and binge eating disorder (BED) are both serious eating disorders characterized by episodes of consuming large amounts of food, a behavior called binge eating. The primary difference ...

The Journal of Eating Disorders has a “Comment” article type: “short, narrowly focused articles of contemporary interest.” This felt like a good fit for some thinking about eating disorder treatment ...